356 related articles for article (PubMed ID: 15028725)
21. Role of AMP-activated protein kinase in the control of appetite.
Kola B
J Neuroendocrinol; 2008 Jul; 20(7):942-51. PubMed ID: 18445126
[TBL] [Abstract][Full Text] [Related]
22. Regulation of ERK1/2 by ouabain and Na-K-ATPase-dependent energy utilization and AMPK activation in parotid acinar cells.
Soltoff SP; Hedden L
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C590-9. PubMed ID: 18632735
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside is independent of AMP-activated protein kinase activation.
Jacobs RL; Lingrell S; Dyck JRB; Vance DE
J Biol Chem; 2007 Feb; 282(7):4516-4523. PubMed ID: 17179149
[TBL] [Abstract][Full Text] [Related]
24. Dorsal hindbrain 5'-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance.
Hayes MR; Skibicka KP; Bence KK; Grill HJ
Endocrinology; 2009 May; 150(5):2175-82. PubMed ID: 19116341
[TBL] [Abstract][Full Text] [Related]
25. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity.
Mountjoy PD; Bailey SJ; Rutter GA
Diabetologia; 2007 Jan; 50(1):168-77. PubMed ID: 17093945
[TBL] [Abstract][Full Text] [Related]
26. AICAR stimulates IL-6 production via p38 MAPK in cardiac fibroblasts in adult mice: a possible role for AMPK.
Du JH; Xu N; Song Y; Xu M; Lu ZZ; Han C; Zhang YY
Biochem Biophys Res Commun; 2005 Dec; 337(4):1139-44. PubMed ID: 16229818
[TBL] [Abstract][Full Text] [Related]
27. Participation of hindbrain AMP-activated protein kinase in glucoprivic feeding.
Li AJ; Wang Q; Ritter S
Diabetes; 2011 Feb; 60(2):436-42. PubMed ID: 21270255
[TBL] [Abstract][Full Text] [Related]
28. 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside stimulates tyrosine hydroxylase activity and catecholamine secretion by activation of AMP-activated protein kinase in PC12 cells.
Fukuda T; Ishii K; Nanmoku T; Isobe K; Kawakami Y; Takekoshi K
J Neuroendocrinol; 2007 Aug; 19(8):621-31. PubMed ID: 17620104
[TBL] [Abstract][Full Text] [Related]
29. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
Perrin C; Knauf C; Burcelin R
Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
[TBL] [Abstract][Full Text] [Related]
30. Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose.
Burmeister MA; Ayala J; Drucker DJ; Ayala JE
Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E677-85. PubMed ID: 23341495
[TBL] [Abstract][Full Text] [Related]
31. AMP-activated protein kinase phosphorylates transcription factors of the CREB family.
Thomson DM; Herway ST; Fillmore N; Kim H; Brown JD; Barrow JR; Winder WW
J Appl Physiol (1985); 2008 Feb; 104(2):429-38. PubMed ID: 18063805
[TBL] [Abstract][Full Text] [Related]
32. Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation.
Fernø J; Varela L; Skrede S; Vázquez MJ; Nogueiras R; Diéguez C; Vidal-Puig A; Steen VM; López M
PLoS One; 2011; 6(6):e20571. PubMed ID: 21695181
[TBL] [Abstract][Full Text] [Related]
33. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides.
Shimokawa T; Kumar MV; Lane MD
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):66-71. PubMed ID: 11756683
[TBL] [Abstract][Full Text] [Related]
34. AMPK activation with AICAR provokes an acute fall in plasma [K+].
Zheng D; Perianayagam A; Lee DH; Brannan MD; Yang LE; Tellalian D; Chen P; Lemieux K; Marette A; Youn JH; McDonough AA
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C126-35. PubMed ID: 18003746
[TBL] [Abstract][Full Text] [Related]
35. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.
Jhun BS; Jin Q; Oh YT; Kim SS; Kong Y; Cho YH; Ha J; Baik HH; Kang I
Biochem Biophys Res Commun; 2004 May; 318(2):372-80. PubMed ID: 15120611
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle.
Cha SH; Hu Z; Chohnan S; Lane MD
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14557-62. PubMed ID: 16203972
[TBL] [Abstract][Full Text] [Related]
37. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.
Tu Y; Thupari JN; Kim EK; Pinn ML; Moran TH; Ronnett GV; Kuhajda FP
Endocrinology; 2005 Jan; 146(1):486-93. PubMed ID: 15498887
[TBL] [Abstract][Full Text] [Related]
38. Fatty acid synthase inhibitors modulate energy balance via mammalian target of rapamycin complex 1 signaling in the central nervous system.
Proulx K; Cota D; Woods SC; Seeley RJ
Diabetes; 2008 Dec; 57(12):3231-8. PubMed ID: 18776140
[TBL] [Abstract][Full Text] [Related]
39. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion.
Clegg DJ; Wortman MD; Benoit SC; McOsker CC; Seeley RJ
Diabetes; 2002 Nov; 51(11):3196-201. PubMed ID: 12401710
[TBL] [Abstract][Full Text] [Related]
40. AICAR, an AMPK activator, has protective effects on alcohol-induced fatty liver in rats.
Tomita K; Tamiya G; Ando S; Kitamura N; Koizumi H; Kato S; Horie Y; Kaneko T; Azuma T; Nagata H; Ishii H; Hibi T
Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):240S-5S. PubMed ID: 16385230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
